[go: up one dir, main page]

DE69210601D1 - Verfahren zur konditionierung wasserlöslicher substanzen - Google Patents

Verfahren zur konditionierung wasserlöslicher substanzen

Info

Publication number
DE69210601D1
DE69210601D1 DE69210601T DE69210601T DE69210601D1 DE 69210601 D1 DE69210601 D1 DE 69210601D1 DE 69210601 T DE69210601 T DE 69210601T DE 69210601 T DE69210601 T DE 69210601T DE 69210601 D1 DE69210601 D1 DE 69210601D1
Authority
DE
Germany
Prior art keywords
soluble substances
conditioning water
vacuum
water
micronised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69210601T
Other languages
English (en)
Other versions
DE69210601T2 (de
Inventor
Jan Trofast
Eva Trofast
Katarina Bystroem
Edib Jakupovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69210601(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of DE69210601D1 publication Critical patent/DE69210601D1/de
Publication of DE69210601T2 publication Critical patent/DE69210601T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treating Waste Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
DE69210601T 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen Expired - Lifetime DE69210601T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances
PCT/SE1992/000186 WO1992018110A1 (en) 1991-04-11 1992-03-24 Process for conditioning of water-soluble substances

Publications (2)

Publication Number Publication Date
DE69210601D1 true DE69210601D1 (de) 1996-06-13
DE69210601T2 DE69210601T2 (de) 1996-10-02

Family

ID=20382434

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69210601T Expired - Lifetime DE69210601T2 (de) 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen
DE69232207T Expired - Lifetime DE69232207T2 (de) 1991-04-11 1992-03-24 Konditionierte wasserlösliche Substanzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69232207T Expired - Lifetime DE69232207T2 (de) 1991-04-11 1992-03-24 Konditionierte wasserlösliche Substanzen

Country Status (28)

Country Link
US (1) US5562923A (de)
EP (3) EP0508969A1 (de)
JP (2) JP3400999B2 (de)
KR (1) KR100216384B1 (de)
AT (2) ATE137671T1 (de)
AU (1) AU662519B2 (de)
BG (1) BG61474B1 (de)
CA (1) CA2106975C (de)
CZ (1) CZ286936B6 (de)
DE (2) DE69210601T2 (de)
DK (2) DK0580648T3 (de)
EE (1) EE02970B1 (de)
ES (2) ES2086733T3 (de)
FI (1) FI105388B (de)
GR (1) GR3020602T3 (de)
HK (1) HK52497A (de)
HU (1) HU211116B (de)
IE (1) IE921144A1 (de)
IS (1) IS3834A (de)
NO (1) NO311867B1 (de)
PL (1) PL168232B1 (de)
PT (1) PT680752E (de)
RO (1) RO115779B1 (de)
RU (1) RU2112507C1 (de)
SE (1) SE9101090D0 (de)
SG (1) SG43180A1 (de)
SK (1) SK280310B6 (de)
WO (1) WO1992018110A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
WO1996026726A1 (en) * 1995-02-28 1996-09-06 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
PL208480B1 (pl) * 1997-03-20 2011-05-31 Schering Corp System dozujący
UA60335C2 (uk) * 1997-08-26 2003-10-15 Хехст Маріон Рассел, Інк. Фармацевтична композиція, яка об'єднує піперидиноалканол з протинабряковим агентом
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
NZ503464A (en) * 1997-09-29 2002-05-31 Inhale Therapeutic Syst Perforated microparticles containing a bioactive agent for pulmonary delivery
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826286D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826284D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
CA2519779A1 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
PL1844765T3 (pl) * 2003-06-13 2015-06-30 Skendi Finance Ltd Formulacja estradiol-progesteron o spowolnionym uwalnianiu
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2005037539A1 (en) * 2003-10-17 2005-04-28 E.I. Dupont De Nemours And Company Adhesion of foil to thermoplastic polymers
CA2554927A1 (en) 2004-02-03 2005-08-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
AU2008334543B2 (en) * 2007-12-13 2011-07-28 Novartis Ag Organic compounds
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
US20110224229A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Novel Crystalline Form
CA2839398A1 (en) 2011-06-29 2013-01-03 Bayer Intellectual Property Gmbh Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders
AU2014228414B2 (en) * 2013-03-15 2018-09-13 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
WO1986007547A1 (en) * 1985-06-21 1986-12-31 Gerhard Gergely Process and device for handling processing material and the reaction product manufactured with the aid of the process and/or device
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
KR100229754B1 (ko) * 1989-11-24 1999-11-15 샬러 한스, 하우스 한스 루돌프 판크레아틴구형입자, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
SK108893A3 (en) 1994-03-09
WO1992018110A1 (en) 1992-10-29
GR3020602T3 (en) 1996-10-31
US5562923A (en) 1996-10-08
HUT65095A (en) 1994-04-28
AU1534792A (en) 1992-11-17
CA2106975A1 (en) 1992-10-12
EP0680752A2 (de) 1995-11-08
EP0508969A1 (de) 1992-10-14
DE69232207D1 (de) 2001-12-20
DK0680752T3 (da) 2002-02-25
NO311867B1 (no) 2002-02-11
FI105388B (fi) 2000-08-15
PL168232B1 (pl) 1996-01-31
DE69210601T2 (de) 1996-10-02
HU211116B (en) 1995-10-30
JP2003155228A (ja) 2003-05-27
EP0580648B1 (de) 1996-05-08
IE921144A1 (en) 1992-10-21
RO115779B1 (ro) 2000-06-30
JP3400999B2 (ja) 2003-04-28
NO933575D0 (no) 1993-10-06
SE9101090D0 (sv) 1991-04-11
EP0580648A1 (de) 1994-02-02
JPH06506454A (ja) 1994-07-21
CZ211693A3 (en) 1994-04-13
ES2086733T3 (es) 1996-07-01
EE02970B1 (et) 1997-04-15
EP0680752B1 (de) 2001-11-14
CA2106975C (en) 2002-03-19
ATE137671T1 (de) 1996-05-15
KR100216384B1 (ko) 1999-08-16
BG98147A (bg) 1994-12-02
IS3834A (is) 1992-10-12
PT680752E (pt) 2002-05-31
HK52497A (en) 1997-05-02
ATE208613T1 (de) 2001-11-15
HU9302870D0 (en) 1993-12-28
SK280310B6 (sk) 1999-11-08
RU2112507C1 (ru) 1998-06-10
SG43180A1 (en) 1997-10-17
DK0580648T3 (da) 1996-09-16
CZ286936B6 (cs) 2000-08-16
EP0680752A3 (de) 1995-11-22
DE69232207T2 (de) 2002-08-01
ES2168322T3 (es) 2002-06-16
FI934429L (fi) 1993-10-08
NO933575L (no) 1993-10-06
BG61474B1 (en) 1997-09-30
FI934429A0 (fi) 1993-10-08
AU662519B2 (en) 1995-09-07

Similar Documents

Publication Publication Date Title
DE69210601D1 (de) Verfahren zur konditionierung wasserlöslicher substanzen
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
MX166765B (es) Metodo para esterilizar superficies contaminadas microbiologicamente a temperaturas y humedades ambientales
ES2144868T3 (es) Metodo de tratamiento de superficie por via seca y dispositivo para la aplicacion de un metodo asi.
DE3164422D1 (en) Immunosuppressive compound, process for isolating it and its therapeutical use
IT7924258A0 (it) Apparato e metodo per manovrare pneumatici non vulcanizzati.
DE69213889D1 (de) Zur Verhinderung von Lecks in die Umwelt geeigneter Injektor für schädliche Gase, insbesondere für Kühlgase
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
ES2030143T3 (es) Dispositivo y procedimiento que permiten aplicar hilos sobre soportes.
DE69205050D1 (de) Verfahren zur Sorption von Restgasen, insbesondere von Stickstoff mittels eines nichtverdampfbaren Bariumgetters.
DE69713102D1 (de) Materialen mit ferromagnetischen eigenschaften, organischen verbindungen mit ferromagnetischen eigenschaften enthaltend und verfahren zu deren herstellung
IL90242A0 (en) A process for drying water-wet polycarbonate membranes
SE8406387L (sv) Sperrhjulsanordning
EP0278515A3 (en) Chloramine removing means
ATE209563T1 (de) Verfahren und vorrichtung zur herstellung einer flexiblen schlauchkombination
ATE157282T1 (de) Verfahren zur herstellung einer aktiven zusammensetzung und damit hergestellte zusammensetzung
DE59501234D1 (de) Verfahren zur Herstellung von 2-Nitrobenzaldehyden
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
JPS5232042A (en) Method to prevent polyethylene cross-linked with organosilane from deg radation
JPS6440922A (en) Dew condensation preventing method for optical unit
EP1059166B8 (de) Verfahren und Vorrichtung zum Trocknen von Druckerzeugnissen
JPS5257511A (en) Cylindrical body correcting device
JPS51131552A (en) A coating method
JPS51117969A (en) Curing apparatus using electron beam irradiation
SE9000327D0 (sv) Combustion and heating system

Legal Events

Date Code Title Description
8364 No opposition during term of opposition